What is the appropriate Rifampin dosing for adults and children for latent and active tuberculosis, including adjustments for hepatic impairment?

Rifampin Dosing for Tuberculosis

For active tuberculosis in adults, use rifampin 10 mg/kg daily (typically 600 mg maximum) as part of standard multi-drug therapy, and for children use 10-20 mg/kg daily (maximum 600 mg). 12

Active Tuberculosis Dosing

Adults

• Daily dosing: 10 mg/kg (typically 600 mg maximum) 12
• Twice-weekly: 10 mg/kg (typically 600 mg) 1
• Thrice-weekly: 10 mg/kg (typically 600 mg) 1

For adults weighing <50 kg, use 450 mg daily; for those >50 kg, use 600 mg daily 33

Children

• Daily dosing: 10-20 mg/kg (maximum 600 mg) 12
• Twice-weekly: 10-20 mg/kg 1
• Thrice-weekly: 10-20 mg/kg 1

Adult dosing begins at age 15 years or weight >40 kg 1

Standard Regimen Structure

The 2016 ATS/CDC/IDSA guidelines recommend a 6-month regimen: 2 months intensive phase with rifampin, isoniazid, pyrazinamide, and ethambutol, followed by 4 months continuation phase with rifampin and isoniazid 1. The 2025 update now includes a 4-month option for eligible adults with pulmonary TB 4.

Latent Tuberculosis Infection (LTBI) Dosing

For LTBI, the preferred regimen is 4 months of daily rifampin at 10 mg/kg (maximum 600 mg) in adults. 52

Preferred LTBI Regimens (2020 CDC Guidelines)

• 4 months rifampin daily: Strong recommendation, moderate certainty evidence for HIV-negative adults 5
• 3 months isoniazid plus rifapentine weekly: Alternative preferred option 5
• 3 months isoniazid plus rifampin daily: Conditional recommendation 5

The 2000 guidelines previously recommended rifampin for 4 months as an acceptable alternative for those who cannot tolerate pyrazinamide 6, but the 2020 update elevated this to a preferred regimen based on improved evidence 5.

Special Populations

Obesity

For obese patients (>20% above ideal body weight), consider dosing based on ideal body weight or modified ideal body weight: IBW + [0.40 × (actual weight – IBW)] 1. Therapeutic drug monitoring may be warranted 1.

Renal Impairment

No dose adjustment is required for doses ≤600 mg daily in renal failure 22. The half-life increases from 3.6 hours in healthy adults to 5.0 hours (GFR 30-50 mL/min), 7.3 hours (GFR <30 mL/min), and 11.0 hours in anuric patients 2. However, at doses >600 mg daily, dosing adjustments may be necessary 2.

Hepatic Impairment

Exercise extreme caution in patients with hepatic disease. While stable liver disease with normal enzymes may tolerate standard dosing, frequent monitoring of liver function tests is mandatory 7. The FDA label does not provide specific dose adjustments but warns about hepatotoxicity risk 22.

Pregnancy and Lactation

All standard doses of rifampin can be used safely during pregnancy 7. Streptomycin should be avoided due to fetal ototoxicity 7.

HIV Co-infection

Standard rifampin doses are appropriate for HIV-positive patients 15. However, rifampin is contraindicated with ritonavir-boosted saquinavir due to severe hepatocellular toxicity 2. Rifampin induces metabolism of protease inhibitors and NNRTIs, requiring careful drug interaction management 2.

Administration Guidelines

Administer rifampin once daily, either 1 hour before or 2 hours after meals with a full glass of water 2. Food reduces absorption by approximately 30% 2.

Pediatric Liquid Suspension

For children unable to swallow capsules, prepare a 1% w/v suspension (10 mg/mL) using rifampin capsule contents mixed with simple syrup 2. This suspension is stable for 4 weeks at room temperature or refrigerated 2.

Higher Dose Considerations

While the 2016 guidelines note that higher doses up to 35 mg/kg are being studied in clinical trials 1, current evidence does not support routine use of doses >10 mg/kg for standard treatment. A 2023 trial showed that 4-month regimens with rifampin 1200-1800 mg daily failed to meet noninferiority criteria compared to standard 6-month treatment 8. A 2024 meta-analysis found increased risk of drug-induced liver injury at doses >20 mg/kg, particularly at 40 mg/kg 910.

Critical Monitoring

• Baseline hepatic enzymes, bilirubin, serum creatinine, complete blood count, and platelet count in adults 2
• Monthly clinical assessment for symptoms of adverse reactions 2
• Rifampin causes orange-red discoloration of body fluids (urine, sweat, tears) and can permanently stain soft contact lenses 2
• Rifampin is a potent inducer of CYP450 enzymes and may reduce efficacy of oral contraceptives—advise alternative contraceptive measures 2